Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
(
- Contribution to journal › Article
- 2022
-
Mark
LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice
(
- Contribution to journal › Article
-
Mark
Osteomodulin Gene Expression Is Associated with Plaque Calcification, Stability, and Fewer Cardiovascular Events in the CPIP Cohort
(
- Contribution to journal › Article
-
Mark
Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification
(
- Contribution to journal › Article
-
Mark
High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women
(
- Contribution to journal › Article
- 2021
-
Mark
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
(
- Contribution to journal › Article
-
Mark
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis
2021) In Journal of Internal Medicine(
- Contribution to journal › Article
-
Mark
Soluble CD40 levels in plasma are associated with cardiovascular disease and in carotid plaques with a vulnerable phenotype
(
- Contribution to journal › Article
-
Mark
Autoantibodies against methylglyoxal-modified apolipoprotein B100 and apob100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term type 1 diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion
(
- Contribution to journal › Article